These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 2550076)

  • 1. Metabolism of pyrenedecanoic acid in Epstein-Barr virus-transformed lymphoid cell lines from normal subjects and from a patient with multisystemic lipid storage myopathy.
    Radom J; Salvayre R; Negre A; Douste-Blazy L
    Biochim Biophys Acta; 1989 Sep; 1005(2):130-6. PubMed ID: 2550076
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Influence of chain length of pyrene fatty acids on their uptake and metabolism by Epstein-Barr-virus-transformed lymphoid cell lines from a patient with multisystemic lipid storage myopathy and from control subjects.
    Radom J; Salvayre R; Levade T; Douste-Blazy L
    Biochem J; 1990 Jul; 269(1):107-13. PubMed ID: 2165389
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metabolism of 1-pyrenedecanoic acid and accumulation of neutral fluorescent lipids in cultured fibroblasts of multisystemic lipid storage myopathy.
    Radom J; Salvayre R; Maret A; Nègre A; Douste-Blazy L
    Biochim Biophys Acta; 1987 Jul; 920(2):131-9. PubMed ID: 3607075
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metabolism of neutral lipids in cultured fibroblasts from multisystemic (or type 3) lipid storage myopathy.
    Radom J; Salvayre R; Negre A; Maret A; Douste-Blazy L
    Eur J Biochem; 1987 May; 164(3):703-8. PubMed ID: 3569285
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biochemical and ultrastructural features of human fibroblasts cultured from a new variant of type 3 lipid storage myopathy.
    Radom J; Salvayre R; Mussini JM; De Lisle B; Negre A; Maret A; Billaudel S; Douste-Blazy L
    Biol Cell; 1988; 62(1):39-45. PubMed ID: 3365518
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Independence of triacylglycerol-containing compartments in cultured fibroblasts from Wolman disease and multisystemic lipid storage myopathy.
    Salvayre R; Nègre A; Radom J; Douste-Blazy L
    FEBS Lett; 1989 Jun; 250(1):35-9. PubMed ID: 2737299
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Extracellular origin of the lipid lysosomal storage in cultured fibroblasts from Wolman's disease.
    Salvayre R; Negre A; Maret A; Radom J; Douste-Blazy L
    Eur J Biochem; 1987 Dec; 170(1-2):453-8. PubMed ID: 3691534
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lymphoid cell lines as a model system for the study of Wolman's disease: enzymatic, metabolic and ultrastructural investigations.
    Nègre A; Salvayre R; Maret A; Vieu C; Bes JC; Borrone C; Durand P; Douste-Blazy L
    J Inherit Metab Dis; 1986; 9(2):193-201. PubMed ID: 3018358
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enzyme studies on Epstein-Barr virus-transformed lymphoid cell lines from Wolman's disease. Lipases, cholesterol esterase and 4-methylumbelliferyl acyl ester hydrolases.
    Negre A; Salvayre R; Durand P; Lenoir G; Douste-Blazy L
    Biochim Biophys Acta; 1984 Jun; 794(1):89-95. PubMed ID: 6329310
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metabolic consequences of adipose triglyceride lipase deficiency in humans: an in vivo study in patients with neutral lipid storage disease with myopathy.
    Natali A; Gastaldelli A; Camastra S; Baldi S; Quagliarini F; Minicocci I; Bruno C; Pennisi E; Arca M
    J Clin Endocrinol Metab; 2013 Sep; 98(9):E1540-8. PubMed ID: 23824421
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Wolman disease and cholesterol ester storage disease in adults. New means of study and diagnosis].
    Salvayre R; Nègre A; Maret A; Radom J; Douste-Blazy L
    Ann Biol Clin (Paris); 1986; 44(6):611-7. PubMed ID: 3826777
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The turnover of cytoplasmic triacylglycerols in human fibroblasts involves two separate acyl chain length-dependent degradation pathways.
    Hilaire N; Salvayre R; Thiers JC; Bonnafé MJ; Nègre-Salvayre A
    J Biol Chem; 1995 Nov; 270(45):27027-34. PubMed ID: 7592952
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acid lipase and carboxylesterases in EBV-transformed lymphoid cell line from Wolman's disease: influence of fatty acid structure of substrate.
    Negre A; Salvayre R; Vuillaume M; Durand P; Douste-Blazy L
    Enzyme; 1984; 31(4):241-6. PubMed ID: 6088221
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Carnitine deficiency of human skeletal muscle with associated lipid storage myopathy: a new syndrome.
    Engel AG; Angelini C
    Science; 1973 Mar; 179(4076):899-902. PubMed ID: 4687787
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of bezafibrate treatment in a patient and a carrier with mutations in the PNPLA2 gene, causing neutral lipid storage disease with myopathy.
    van de Weijer T; Havekes B; Bilet L; Hoeks J; Sparks L; Bosma M; Paglialunga S; Jorgensen J; Janssen MC; Schaart G; Sauerwein H; Smeets JL; Wildberger J; Zechner R; Schrauwen-Hinderling VB; Hesselink MK; Schrauwen P
    Circ Res; 2013 Mar; 112(5):e51-4. PubMed ID: 23449549
    [No Abstract]   [Full Text] [Related]  

  • 16. Generation of induced Pluripotent Stem Cells as disease modelling of NLSDM.
    Tavian D; Missaglia S; Castagnetta M; Degiorgio D; Pennisi EM; Coleman RA; Dell'Era P; Mora C; Angelini C; Coviello DA
    Mol Genet Metab; 2017 May; 121(1):28-34. PubMed ID: 28391974
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neutral lipid storage disease with ichthyosis: lipid content and metabolism of fibroblasts.
    Williams ML; Monger DJ; Rutherford SL; Hincenbergs M; Rehfeld SJ; Grunfeld C
    J Inherit Metab Dis; 1988; 11(2):131-43. PubMed ID: 3139924
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relative fluorescence of normal and acid lipase-deficient cultured fibroblasts following administration of pyrene decanoic acid.
    Nègre A; Maret A; Douste-Blazy L; Gatt S; Salvayre R
    Biochim Biophys Acta; 1988 Jun; 960(3):401-9. PubMed ID: 3382681
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neutral lipid storage disease: a possible functional defect in phospholipid- linked triacylglycerol metabolism.
    Williams ML; Coleman RA; Placezk D; Grunfeld C
    Biochim Biophys Acta; 1991 Feb; 1096(2):162-9. PubMed ID: 2001430
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neutral lipid storage with acid lipase deficiency: a new variant of Wolman's disease with features of the Senior syndrome.
    Philippart M; Durand P; Borrone C
    Pediatr Res; 1982 Nov; 16(11):954-9. PubMed ID: 7155665
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.